Clinical Trial: Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Follicular Lymphoma
Study Type: INTERVENTIONAL
Official Title: A Phase 2 Study of Glofitamab and Obinutuzumab for First-line Treatment of Follicular Lymphoma and Marginal Zone Lymphoma
Brief Summary:
The purpose of this study is to determine how effective and safe the combination of glofitamab and obinutuzumab is in treating patients with Follicular Lymphoma (FL) and Marginal Zone Lymphoma (MZL) who have not received other treatments for their lymphoma.The names of the study drugs involved in this study are:Glofitamab (a type of immunotherapy)Obinutuzumab (a type of immunotherapy)
Read more